Lansoprazole prevents the progression of liver fibrosis in non ‐alcoholic steatohepatitis model rats

ConclusionsLansoprazole inhibits hepatic fibrogenesis, at least during the early stages, in CDAA diet‐induced NASH model rats. The mechanisms might be associated with cytokine suppression but not the inhibition of reactive oxygen species.

Source: Journal of Pharmacy and Pharmacology - January 22, 2018 Category: Drugs & Pharmacology Authors: Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama Tags: Research Paper Source Type: research